Apnimed, Inc. (APMD) Ownership
APMD ownership summary
as of October 17, 2026- Institutions
- 24.9% of shares outstanding
- Insiders
- 35.61% of shares outstanding
- Shares outstanding
- 41.6M
- Float
- 20.5M shares available to trade
- Short interest
- — 1.8M shares short
- Days to cover
- 3.08 short interest up 100.6% vs prior month
- Institutions 24.93%
- Insiders 35.61%
- Other investors 39.46%
APMD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Columbia Seligman Tech & Info A | 17.30% | 7.2M | $127.9M | — | August 31, 2026 |
| 2 | JPMorgan Small Cap Growth A | 1.19% | 495K | $8.8M | +495,265 (0.0%) | August 31, 2026 |
| 3 | PGIM Jennison Health Sciences Z | 1.18% | 489K | $8.7M | +489,054 (0.0%) | August 31, 2026 |
| 4 | Highland Global Allocation A | 0.97% | 405K | $7.2M | +405,378 (0.0%) | August 31, 2026 |
| 5 | iShares Russell 2000 ETF | 0.74% | 308K | $5.5M | −3,520 (−1.1%) | September 30, 2026 |
| 6 | AB Small Cap Growth A | 0.72% | 299K | $5.3M | +299,272 (0.0%) | August 31, 2026 |
| 7 | abrdn Healthcare Investors | 0.54% | 225K | $4.0M | — | August 31, 2026 |
| 8 | abrdn Healthcare Opportunities | 0.42% | 175K | $3.1M | — | August 31, 2026 |
| 9 | JPMorgan Small Cap Blend A | 0.38% | 157K | $2.8M | +157,256 (0.0%) | August 31, 2026 |
| 10 | Fidelity Contrafund | 0.30% | 127K | $2.3M | +126,857 (0.0%) | August 31, 2026 |
| 11 | abrdn Life Sciences Investors | 0.27% | 112K | $2.0M | — | August 31, 2026 |
| 12 | abrdn World Healthcare | 0.27% | 112K | $2.0M | — | August 31, 2026 |
| 13 | Fidelity Select Biotechnology | 0.22% | 92K | $1.6M | +92,400 (0.0%) | August 31, 2026 |
| 14 | JPMorgan Small Cap Value I | 0.22% | 92K | $1.6M | +92,206 (0.0%) | August 31, 2026 |
| 15 | Principal SmallCap Growth I Instl | 0.22% | 92K | $1.6M | +91,968 (0.0%) | August 31, 2026 |
| 16 | Multi-Manager Small Cap Eq Strat Inst | 0.19% | 78K | $1.4M | +78,149 (0.0%) | August 31, 2026 |
| 17 | JPMorgan US Small Company L | 0.19% | 78K | $1.4M | +77,559 (0.0%) | August 31, 2026 |
| 18 | iShares Russell 2000 Growth ETF | 0.17% | 69K | $1.2M | −87 (−0.1%) | September 30, 2026 |
| 19 | Schwab US Small-Cap ETF™ | 0.15% | 62K | $1.1M | +36 (+0.1%) | September 30, 2026 |
| 20 | Vanguard MStar Total Stk Mkt Idx Invest | 0.15% | 62K | $1.1M | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
Who owns APMD
Institutional investors own 24.9% of Apnimed's shares and insiders 35.61%.
Related: APMD analyst forecast, APMD key metrics. See the APMD stock overview for the latest quote and news.
APMD ownership FAQ
What percentage of Apnimed is owned by institutions?
Institutions hold 24.9% of Apnimed's shares outstanding; insiders hold 35.61%.
Which funds own Apnimed?
The largest fund holders of Apnimed are Columbia Seligman Tech & Info A (17.30%), JPMorgan Small Cap Growth A (1.19%), PGIM Jennison Health Sciences Z (1.18%), Highland Global Allocation A (0.97%), iShares Russell 2000 ETF (0.74%).
How many shares of Apnimed are outstanding?
Apnimed has 41.6M shares outstanding, of which 20.5M are in the public float.